Magnetic resonance (MR) imaging to assess the risk for disease progression in patients with stage I multiple myeloma (MMI) and monoclonal gammapathy of undetermined significance (MGUS).

Berg, BV.; Michaux, Lucienne; Lecouvet, Frédéric; Ferrant, Augustin; Malghem, Jacques; Labaisse, MA; Maldague, Baudouin; Michaux, JL.

Magnetic resonance (MR) imaging to assess the risk for disease progression in patients with stage I multiple myeloma (MMI) and monoclonal gammapathy of undetermined significance (MGUS).

Berg, BV.

;

Michaux, Lucienne

;

Lecouvet, Frédéric

;

Ferrant, Augustin

;

Michaux, JL.

;et.al.

(1995)

Files

No attached file found for this publication.

Details

Authors

Berg, BV.
Author
Michaux, LucienneUCLouvain
Author
Lecouvet, FrédéricUCLouvain
Author
Ferrant, AugustinUCLouvain
Author
Malghem, JacquesUCLouvain
Author
Maldague, BaudouinUCLouvain
Author
Michaux, JL.
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne
UCLouvainMD/RAIM - Département de radiologie et d'imagerie médicale

Citations

APA
Chicago
FWB

Berg, BV., Michaux, L., Lecouvet, F., Ferrant, A., Malghem, J., Labaisse, M., Maldague, B., & Michaux, JL. (1995). Magnetic resonance (MR) imaging to assess the risk for disease progression in patients with stage I multiple myeloma (MMI) and monoclonal gammapathy of undetermined significance (MGUS). Blood, 86(10), 3364. (Original work published 1995)